December 2022 • PharmaTimes Magazine • 4-5


Contents


Features

Improving LGBTQ+ access to clinical trials makes sense for everyone


Closing the healthcare inequity gap in our communities is essential


We must protect the innovation that creates life-saving treatments


Diabetes is still a global crisis and one we need to urgently address


How do we ensure retinal care incorporates healthy equity?


Analysis

Industry fails to attract talent, as scientific representation worsens


Intelligent resourcing – what it means and why it’s important


Building skills to deliver the data-centric regulatory vision


Big data meets big pharma – the future of drug development


Being in partnerships means the NHS is getting treatments to patients faster


SmartPeople

12.
Trial blazers
Addressing diversity and inclusion in clinical trials is a story of our times


13.
Reality checked
As in so many areas of life, pharma can be pioneers of sustainability


26.
You’ve been frame worked
Key changes to the European Market Access Landscape have emerged


27.
History channel
Collaboration is critical to seeing further and with much more clarity


34.
Your moves
Where you are going and what you'll be doing when you get there